The Next Vaccine Debate: Immunize Young Children Now, or Wait?
The Food and Drug Administration’s upcoming review of the Pfizer-BioNTech coronavirus vaccine for young children is without precedent in recent history. Next week, scientific advisers to the agency will decide whether to endorse two doses of the vaccine for children 6 months through 4 years of age, before clinical trials have shown the full course…